Assessment of two emergency contraceptive regimens in Iran: levonorgestrel versus the Yuzpe
- PMID: 20329690
Assessment of two emergency contraceptive regimens in Iran: levonorgestrel versus the Yuzpe
Abstract
Objective: The purpose of this study was to compare the efficacy and tolerability of two emergency contraception (EC) methods, levonorgestrel versus the Yuzpe.
Methods: In a prospective, randomized, comparative study, we included 122 healthy volunteers who in the observed cycle had had only one act of unprotected intercourse within 72 h of treatment. They were randomly allocated in levonorgestrol group (n=62) and Yuzpe (n=60). The levonorgestrel regimen consisted of two pills: 0.75 mg levonorgestrel, taken twice in the 12-h interval within 72 h after unprotected intercourse. The Yuzpe method included two HD contraceptive pills taken as another regimen. Data were collected by questionnaire at first and 3 weeks later. The differences were compared with X2 & Fisher exact tests.
Results: There were no significant differences between two groups in any of the observed parameters. The levonorgestrel regimen was found superior to Yuzpe because it's more effectiveness (respectively 100% vs 91%, p=0.026) and fewer side effects.
Conclusion: The study showed more effectiveness and safety of the levonorgestrel regimen as emergency contraception. Thus we recommend levonorgestrel as an alternative EC method instead of the Yuzpe regimen in Iran or other developing countries in order to decrease unwanted pregnancy.
Similar articles
-
Levonorgestrel versus the "Yuzpe" regimen. New choices in emergency contraception.Can Fam Physician. 1999 Mar;45:629-31. Can Fam Physician. 1999. PMID: 10099801 Free PMC article. Clinical Trial.
-
A randomized clinical trial of two emergency contraceptive pill regimens in a Ugandan population.Acta Obstet Gynecol Scand. 2010 May;89(5):670-6. doi: 10.3109/00016341003611220. Acta Obstet Gynecol Scand. 2010. PMID: 20423278 Clinical Trial.
-
Levonorgestrel is more effective, has fewer side-effects, than Yuzpe regimen.Prog Hum Reprod Res. 1999;(51):3-5. Prog Hum Reprod Res. 1999. PMID: 12349416
-
Postcoital contraception: present and future options.J Adolesc Health. 1995 Jan;16(1):6-11. doi: 10.1016/1054-139X(94)00055-J. J Adolesc Health. 1995. PMID: 7742340 Review.
-
Expanding access to emergency contraception in developing countries.Stud Fam Plann. 1995 Sep-Oct;26(5):251-63. Stud Fam Plann. 1995. PMID: 8571440 Review.
Cited by
-
A Comprehensive Integration of Data Regarding the Correlation of TNF-α rs1800629 Polymorphism with Susceptibility to Cervical Cancer.Asian Pac J Cancer Prev. 2024 Apr 1;25(4):1155-1167. doi: 10.31557/APJCP.2024.25.4.1155. Asian Pac J Cancer Prev. 2024. PMID: 38679974 Free PMC article.
-
A Randomized, Controlled Trial of Levonorgestrel Vs. The Yuzpe Regimen as Emergency Contraception Method among Iranian Women.Iran J Public Health. 2013 Oct;42(10):1158-66. Iran J Public Health. 2013. PMID: 26060625 Free PMC article.
-
U.S. Selected Practice Recommendations for Contraceptive Use, 2024.MMWR Recomm Rep. 2024 Aug 8;73(3):1-77. doi: 10.15585/mmwr.rr7303a1. MMWR Recomm Rep. 2024. PMID: 39106301 Free PMC article.
-
Evaluate the Effectiveness of Conservative Treatment for Menorrhagia in Women who were Admitted to the Shahid Sadoughi Hospital of Yazd-Iran in 2014-2015.Int J Biomed Sci. 2016 Sep;12(3):105-109. Int J Biomed Sci. 2016. PMID: 27829826 Free PMC article.
-
A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive.Clin Drug Investig. 2020 May;40(5):395-420. doi: 10.1007/s40261-020-00901-x. Clin Drug Investig. 2020. PMID: 32162237